Correlation Between Bank Mandiri and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank Mandiri and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Mandiri and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Mandiri Persero and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Bank Mandiri and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Mandiri with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Mandiri and Neurobo Pharmaceuticals.
Diversification Opportunities for Bank Mandiri and Neurobo Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Bank and Neurobo is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Bank Mandiri Persero and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Bank Mandiri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Mandiri Persero are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Bank Mandiri i.e., Bank Mandiri and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank Mandiri and Neurobo Pharmaceuticals
Assuming the 90 days horizon Bank Mandiri Persero is expected to under-perform the Neurobo Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bank Mandiri Persero is 1.63 times less risky than Neurobo Pharmaceuticals. The pink sheet trades about -0.12 of its potential returns per unit of risk. The Neurobo Pharmaceuticals is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 239.00 in Neurobo Pharmaceuticals on September 15, 2024 and sell it today you would lose (13.00) from holding Neurobo Pharmaceuticals or give up 5.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 90.48% |
Values | Daily Returns |
Bank Mandiri Persero vs. Neurobo Pharmaceuticals
Performance |
Timeline |
Bank Mandiri Persero |
Neurobo Pharmaceuticals |
Bank Mandiri and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bank Mandiri and Neurobo Pharmaceuticals
The main advantage of trading using opposite Bank Mandiri and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Mandiri position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.Bank Mandiri vs. PT Bank Rakyat | Bank Mandiri vs. Morningstar Unconstrained Allocation | Bank Mandiri vs. Bondbloxx ETF Trust | Bank Mandiri vs. Spring Valley Acquisition |
Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |